BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10739504)

  • 21. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant.
    Faundes A; Tejada AS; Brache V; Alvarez F
    Contraception; 1987 Feb; 35(2):189-96. PubMed ID: 3109804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB; Lobo RA
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A; Alvarez F; Brache V; Tejada AS
    Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Norplant contraceptive implants: opinion of Dominican women who used this method].
    Hardy E; Baez C; Faundes A; Alvarez F; Brache V
    Acta Med Dom; 1990; 12(1):1-6. PubMed ID: 12292702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK; Ramadan M; el-Sawi M; Mehanna MT; Khamis Y; Marzouk S
    Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants.
    Hidalgo MM; Lisondo C; Juliato CT; Espejo-Arce X; Monteiro I; Bahamondes L
    Contraception; 2006 May; 73(5):532-6. PubMed ID: 16627041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception.
    Darney PD; Callegari LS; Swift A; Atkinson ES; Robert AM
    Am J Obstet Gynecol; 1999 Apr; 180(4):929-37. PubMed ID: 10203661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
    Di X; Li Y; Zhang C; Jiang J; Gu S
    Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
    Viegas OA; Koh SC; Ratnam SS
    Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
    Berenson AB; Wiemann CM
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB; Díaz S; Pavez M; Brandeis A
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
    Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Emory method: a modified approach to Norplant implants removal.
    Sarma SP; Hatcher R
    Contraception; 1994 Jun; 49(6):551-6. PubMed ID: 8070259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.